Duration and Budget
Indirect Costs
For research grants, including postdoctoral fellowships, the TSC Alliance allows no more than 10 percent of the total costs to be applied to indirect costs. As an example, a maximum of $15,000 indirect costs may be included within an award totaling $150,000.
The TSC Alliance does not pay indirect costs on contracts based on delivering a tangible or measurable work product. Examples of such contracts are those to enter data into the TSC Natural History Database or collection of blood or remnant surgical tissue for the TSC Biosample Repository.
1. 🧠 Clear Focus on Tuberous Sclerosis Complex (TSC)
The core predictor of success is a research proposal directly relevant to:
Mechanisms of disease (TSC1/TSC2, mTOR pathway)
Preclinical or translational research
Biomarkers and diagnostics
TSC-related epilepsy, autism, or tumors (e.g., SEGAs, angiomyolipomas)
Therapeutic targets and clinical trials
✅ Success Predictor: You propose a study clearly focused on understanding or treating TSC-specific pathophysiology or symptoms.
2. 🧪 Strong Preliminary Data
Competitive applicants often provide:
Pilot data showing feasibility and rationale
Prior studies linking their lab to mTOR/TSC signaling
Publications in neuroscience, genetics, or rare disease journals
✅ Success Predictor: You’ve already engaged in TSC-relevant research, even at a small scale.
3. 👩🔬 Investigator Experience & Institutional Support
TSC Alliance supports:
Established researchers with a strong track record in neurogenetics or rare disease biology
New investigators partnering with experienced mentors
Institutions with neurodevelopmental labs, imaging cores, or access to TSC animal models or patient registries
✅ Success Predictor: You have either a reputation in related fields or a strong mentorship/partnership network.
4. 🔁 Alignment with Ongoing TSC Alliance Initiatives
Your proposal aligns with ongoing TSC Alliance efforts like:
Preclinical Consortium
Clinical Research Consortium
Biosample Repository
Natural History Database
Clinical trials readiness tools
✅ Success Predictor: You integrate with or leverage existing TSC Alliance resources or networks.
5. 🔬 Translational Potential
High-priority projects are those that:
Advance therapeutic development
Provide biomarkers for clinical trials
Bridge basic and clinical science (e.g., from model to patient)
✅ Success Predictor: Your work can translate to real-world TSC treatment or care improvements.
Program | Description | Amount |
---|---|---|
Postdoctoral Fellowships | Support early-career researchers | $75,000–$100,000/year |
Targeted Research Grants | Fund hypothesis-driven studies | ~$75,000–$150,000 |
Preclinical Consortium Projects | For therapeutic screening | Varies (co-funded) |
Biosample/Data Access Grants | Use of TSC databases or biobank | Often included in other grants |
Co-funding opportunities may be available with DoD CDMRP (TSCRP), NIH, or private industry partners.
🧬 Recent Funded Topics (Examples)
Immune dysregulation and inflammation in TSC
Brain connectome abnormalities and seizure focus
Gene therapy vectors targeting TSC1/TSC2 mutations
Drug repurposing for neuropsychiatric symptoms (e.g., everolimus alternatives)
Deep phenotyping in early-onset TSC
Show clear relevance to TSC-specific mechanisms or treatment gaps
Reference TSC Alliance priorities or tools (biobank, database, Natural History Study)
Include patient-centered aims or outcome measures
Highlight collaboration with TSC experts or institutions
For early-career applicants, show solid mentorship plan
This opportunity is open to all investigators at established academic or research institutions or at pharmaceutical or biotech companies worldwide. Researchers residing in the United States do not need to be U.S. citizens to apply for funding.
Sponsor Institute/Organizations: TSC Alliance
Sponsor Type: Corporate/Non-Profit
Address: 8737 Colesville Road, Suite 400 Silver Spring, Maryland 20910-3921 USA 800.225.6872 (Toll-Free) 301.562.9890 info@tscalliance.org EIN: 95-3018799
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Aug 25, 2025
$75,000
Affiliation: TSC Alliance
Address: 8737 Colesville Road, Suite 400 Silver Spring, Maryland 20910-3921 USA 800.225.6872 (Toll-Free) 301.562.9890 info@tscalliance.org EIN: 95-3018799
Website URL: https://www.tscalliance.org/researchers/grants-funding/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.